[Phase II study of VP-16 in patients with primary bronchogenic carcinoma, with special reference to small cell carcinoma--a multi-institutional cooperative study].
作者信息
Kanda T, Oka M, Hara K, Koteda T, Ishizaki T, Ikebe A, Nakano M, Iwasaki H, Tsutsumi T, Okuno K
出版信息
Nihon Gan Chiryo Gakkai Shi. 1986 Feb 20;21(1):12-8.
PMID:3009666
Abstract
摘要
相似文献
1
[Phase II study of VP-16 in patients with primary bronchogenic carcinoma, with special reference to small cell carcinoma--a multi-institutional cooperative study].
Nihon Gan Chiryo Gakkai Shi. 1986 Feb 20;21(1):12-8.
2
Phase II clinical trial of weekly administration of VP-16-213 in small cell bronchogenic carcinoma.
Cancer Treat Rep. 1977 May-Jun;61(3):489-90.
3
[Phase II study of etoposide in patients with lung cancer, with special reference to small cell carcinoma].
Nihon Gan Chiryo Gakkai Shi. 1986 Feb 20;21(1):108-11.
4
[Treatment of bronchopulmonary small cell carcinoma with a combination of cyclophosphamide and VP-16].
Med Clin (Barc). 1984 May 19;82(19):836-9.
5
[A phase II study of oral VP-16 in primary lung cancer].
Gan To Kagaku Ryoho. 1985 Sep;12(9):1801-7.
6
[A phase II study of etoposide (VP-16) injection in primary lung cancer by cooperative study group].
Gan To Kagaku Ryoho. 1986 Jan;13(1):116-21.
7
[A phase II study of NK171 (etoposide)].
Gan To Kagaku Ryoho. 1985 Oct;12(10):2011-7.
8
[A phase II study of intravenous VP-16-213 in small cell and non-small cell carcinoma of the lung].
Gan To Kagaku Ryoho. 1986 Apr;13(4 Pt 1):931-7.
9
Multicenter Phase II trial of etoposide in refractory small cell lung cancer.
Cancer Treat Rep. 1985 Jan;69(1):127-8.
10
Etoposide--an effective single drug for treating bronchogenic carcinoma.
Clin Oncol. 1982;8(3):215-8.
Zotero 插件